Nan Fung Group Holdings’s Rani Therapeutics RANI Stock Holding History

Nan Fung Group Holdings’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Hold	493,584	–	–	0.29%	23
2026 Q1	$363K	Hold	493,584	–	–	0.3%	23
2025 Q4	$666K	Hold	493,584	–	–	0.6%	21
2025 Q3	$247K	Hold	493,584	–	–	0.41%	23
2025 Q2	$254K	Hold	493,584	–	–	0.4%	19
2025 Q1	$622K	Hold	493,584	–	–	0.51%	27
2024 Q4	$676K	Hold	493,584	–	–	0.58%	29
2024 Q3	$1.07M	Hold	493,584	–	–	0.92%	24
2024 Q2	$1.88M	Hold	493,584	–	–	2%	16
2024 Q1	$1.54M	Hold	493,584	–	–	1.42%	20
2023 Q4	$1.64M	Hold	493,584	–	–	1.02%	17
2023 Q3	$1.07M	Hold	493,584	–	–	0.87%	19
2023 Q2	$2.03M	Hold	493,584	–	–	1.3%	14
2023 Q1	$2.55M	Hold	493,584	–	–	1.73%	14
2022 Q4	$2.91M	Hold	493,584	–	–	2.01%	10
2022 Q3	$4.73M	Hold	493,584	–	–	3.02%	7
2022 Q2	$5.1M	Hold	493,584	–	–	3.5%	7
2022 Q1	$6.66M	Hold	493,584	–	–	3.16%	8
2021 Q4	$8.07M	Hold	493,584	–	–	2.39%	9
2021 Q3	$8.8M	Buy	+493,584	New	+$8.54M	2.82%	8

Other funds holding RANI

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nan Fung Group Holdings's RANI Position: Q2 2026 in Review

Nan Fung Group Holdings held its Rani Therapeutics (RANI) position steady in Q2 2026 at 493,584 shares worth $375K. The position accounts for 0.29% of the portfolio, ranked #23.

Nan Fung Group Holdings first reported a position in RANI in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.8M in Q3 2021. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

Nan Fung Group Holdings held 493,584 shares of Rani Therapeutics worth $375K as of Q2 2026.
Nan Fung Group Holdings left its Rani Therapeutics share count unchanged in Q2 2026.
Rani Therapeutics made up 0.29% of Nan Fung Group Holdings's portfolio in Q2 2026, its #23 holding.
Nan Fung Group Holdings first reported a position in Rani Therapeutics in Q3 2021 and has held it in 20 quarters since.
Nan Fung Group Holdings's Rani Therapeutics position peaked at $8.8M in Q3 2021.
68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.